Gerresheimer reports double digit growth in revenue and earnings for the third quarter

Organic revenue growth of 17.4% in the third quarter supported by continued strong demand for High Value Solutions

Organic adjusted EBITDA up 13.3%

Gerresheimer firmly on track to deliver on FY 2022 guidance

DUESSELDORF,Germany,Oct. 12,2022 -- Gerresheimer AG,a leading provider of healthcare & beauty solutions and drug delivery systems for pharma,biotech and cosmetics,confirms guidance for its financial year 2022 after another quarter of strong and profitable growth. Revenue rose organically by 17.4% in the third quarter,reflecting strong customer demand,leading market positions and the ongoing success of its High Value Solutions. Adjusted EBITDA grew organically by 13.3%. "Gerresheimer continues on its profitable growth path across all our divisions,business segments and regions reflecting our strong market positions. While steering successfully through a challenging environment,we are consistently pursuing our growth strategy and are boosting our transformation process to become a solution provider and system integrator",said Dietmar Siemssen,CEO of Gerresheimer AG. "We are on track to deliver on our financial year 2022 guidance,and we are clearly committed to our mid-term targets",he affirmed.

Press release: https://www.gerresheimer.com/en/company/newsroom/corporate-news/detail/gerresheimer-reports-double-digit-growth-in-revenue-and-earnings-for-the-third-quarter

For further information:http://www.presseportal.de/nr/9072/dokument?langid=2

Ueli Utzinger

Group Senior Director Marketing & Communication

T +49 211 6181-250

ueli.utzinger@gerresheimer.com